← SynDRA
ZOTATIFIN
SynDRA canonical compound SYN0039865 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | EIF4A1 |
|---|
| Mechanism of action | eukaryotic translation initiation factor inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- eukaryotic translation initiation factor inhibitor
Cross-references
Synonyms
- Zotatifine
- Zotatifina
- EFT226
- EFT-226
- eFT226
- UNII-2EWN8Z05CN
- 2EWN8Z05CN
- Zotatifin [INN]
- 4-((5aR,6S,7S,8R,8aS)-7-((Dimethylamino)methyl)-8,8a-dihydroxy-1,3-dimethoxy-6-phenyl-6,7,8,8a-tetrahydro-5ah-cyclopenta(4,5)furo(3,2-C)pyridin-5a-yl)benzonitrile
- 4-((5aR,6S,7S,8R,8aS)-7-((Dimethylamino)methyl)-8,8a-dihydroxy-1,3-dimethoxy-6-phenyl-6,7,8,8a-tetrahydro-5aH-cyclopenta[4,5]furo[3,2-c]pyridin-5a-yl)benzonitrile
- Zotatifin [USAN]
- Zotatifin (USAN/INN)
- CHEMBL4303782
- SCHEMBL18864788
- EX-A4623
- NSC818001
- NSC828584
- WHO 10998
- NSC-818001
- NSC-828584
- HY-112163
- CS-0043584
- D11837
- Benzonitrile, 4-((5aR,6S,7S,8R,8aS)-7-((dimethylamino)methyl)-6,7,8,8a-tetrahydro-8,8a-dihydroxy-1,3-dimethoxy-6-phenyl-5ah-cyclopenta(4,5)furo(3,2-C)pyridin-5a-yl)-
- eFT 226
- zotatifinum
- RefChem:1101202
- rel-Zotatifin
- Zotafin
- Zotatifin [USAN:INN]
- ZOTATIFIN [WHO-DD]
- orb1706438
- SCHEMBL29380412
- YQF2810
- GLXC-22555
- BDBM50540861
- AKOS040742848
- NCGC00842104-01
- BZ177457
Look up ZOTATIFIN in the interactive SynDRA portal →